Ken Griffin Aptorum Group LTD Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.14 - $12.9 $42,300 - $478,667	37,106 New	37,106 $43,000
Q1 2022 May 16, 2022	SELL	$1.22 - $2.28 $49,434 - $92,385	-40,520 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.5 - $2.64 $60,780 - $106,972	40,520 New	40,520 $60,000
Q3 2021 Nov 15, 2021	SELL	$2.39 - $3.22 $26,072 - $35,126	-10,909 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.37 - $3.43 $109,287 - $158,167	-46,113 Reduced 80.87%	10,909 $34,000
Q1 2021 May 17, 2021	BUY	$2.45 - $4.17 $90,645 - $154,281	36,998 Added 184.77%	57,022 $170,000
Q4 2020 Feb 16, 2021	BUY	$2.03 - $2.89 $40,648 - $57,869	20,024 New	20,024 $49,000
Q3 2020 Nov 16, 2020	SELL	$1.22 - $4.76 $15,558 - $60,704	-12,753 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.81 - $4.7 $35,835 - $59,939	12,753 New	12,753 $48,000

Ticker APM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,265,500
Market Cap $28.1M
Description
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.